The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1346
ISSUE1346
September 6, 2010
Natazia - A New Oral Contraceptive
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Natazia - A New Oral Contraceptive
September 6, 2010 (Issue: 1346)
The FDA has approved the marketing of Natazia (Bayer), a 4-phase oral contraceptive containing the
estrogen estradiol valerate and the progestin dienogest, both used for the first time in the US for this
indication.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.